Literature DB >> 15338034

High variability of peptidylarginine deiminase 4 (PADI4) in a healthy white population: characterization of six new variants of PADI4 exons 2-4 by a novel haplotype-specific sequencing-based approach.

Berthold Hoppe1, Guido A Heymann, Farzaneh Tolou, Holger Kiesewetter, Thomas Doerner, Abdulgabar Salama.   

Abstract

Seven single nucleotide polymorphisms (SNPs) of the peptidylarginine deiminase 4 (PADI4) gene have recently been reported to be strongly associated with rheumatoid arthritis in Japanese individuals. These SNPs are located in or close to exons 2-4 of PADI4 and are organized in at least four different haplotypes. However, a detailed sequencing-based characterization of the PADI4 gene in other populations is still lacking. We therefore analyzed exons 2-4 of the PADI4 gene in 102 healthy white Germans individuals by DNA sequencing and characterized new variants and haplotypes by a novel haplotype-specific sequencing-based approach. The haplotypes 2/3 (padi4_89*G, padi4_90*T, padi4_92*G, padi4_94*T, padi4_104*T, padi4_95*C, padi4_96*C), and haplotype 4 (padi4_89*G, padi4_90*T, padi4_92*G, padi4_94*T, padi4_104*C, padi4_95*G, padi4_96*T) conferring susceptibility to rheumatoid arthritis were detected at frequencies of 30.9% and 7.8%, respectively. In addition, three novel coding SNPs in exons 2, 3, and 4, and three SNPs in introns 2 and 3 located near the exon-intron boundaries were identified in 11 individuals (10.8%). The so-called nonsusceptibility haplotype 1 (padi4_89*A, padi4_90*C, padi4_92*C, padi4_94*C, padi4_104*C, padi4_95*G, padi4_96*T) occurred at a frequency of 58.3%. Additionally, we identified a closely related novel haplotype, haplotype 1B (2.9%), that differs from haplotype 1 only by padi4_92*G/padi4_96*C. This haplotype was not described in the Japanese population. Our results indicate that the PADI4 gene exhibits a remarkable variability and a rather complex haplotypic organization. Further studies on disease association of PADI4 should be performed by haplotype-specific sequencing-based approaches to identify the exact genotype of the PADI4 fragment of interest.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15338034     DOI: 10.1007/s00109-004-0584-6

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  12 in total

1.  Nuclear localization of peptidylarginine deiminase V and histone deimination in granulocytes.

Authors:  Katsuhiko Nakashima; Teruki Hagiwara; Michiyuki Yamada
Journal:  J Biol Chem       Date:  2002-10-18       Impact factor: 5.157

2.  The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues.

Authors:  E Girbal-Neuhauser; J J Durieux; M Arnaud; P Dalbon; M Sebbag; C Vincent; M Simon; T Senshu; C Masson-Bessière; C Jolivet-Reynaud; M Jolivet; G Serre
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

3.  The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin.

Authors:  C Masson-Bessière; M Sebbag; E Girbal-Neuhauser; L Nogueira; C Vincent; T Senshu; G Serre
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

4.  Enhanced T cell responsiveness to citrulline-containing myelin basic protein in multiple sclerosis patients.

Authors:  L R Tranquill; L Cao; N C Ling; H Kalbacher; R M Martin; J N Whitaker
Journal:  Mult Scler       Date:  2000-08       Impact factor: 6.312

5.  Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved non-coding segments and a new human gene, PADI6.

Authors:  Stéphane Chavanas; Marie-Claire Méchin; Hidenari Takahara; Akira Kawada; Rachida Nachat; Guy Serre; Michel Simon
Journal:  Gene       Date:  2004-04-14       Impact factor: 3.688

6.  Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis.

Authors:  Akari Suzuki; Ryo Yamada; Xiaotian Chang; Shinya Tokuhiro; Tetsuji Sawada; Masakatsu Suzuki; Miyuki Nagasaki; Makiko Nakayama-Hamada; Reimi Kawaida; Mitsuru Ono; Masahiko Ohtsuki; Hidehiko Furukawa; Shinichi Yoshino; Masao Yukioka; Shigeto Tohma; Tsukasa Matsubara; Shigeyuki Wakitani; Ryota Teshima; Yuichi Nishioka; Akihiro Sekine; Aritoshi Iida; Atsushi Takahashi; Tatsuhiko Tsunoda; Yusuke Nakamura; Kazuhiko Yamamoto
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

7.  Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule.

Authors:  Jonathan A Hill; Scott Southwood; Alessandro Sette; Anthony M Jevnikar; David A Bell; Ewa Cairns
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

8.  Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors.

Authors:  Markus M J Nielen; Dirkjan van Schaardenburg; Henk W Reesink; Rob J van de Stadt; Irene E van der Horst-Bruinsma; Margret H M T de Koning; Moud R Habibuw; Jan P Vandenbroucke; Ben A C Dijkmans
Journal:  Arthritis Rheum       Date:  2004-02

Review 9.  Peptidylarginine deiminase type 4: identification of a rheumatoid arthritis-susceptible gene.

Authors:  Ryo Yamada; Akari Suzuki; Xiotian Chang; Kazuhiko Yamamoto
Journal:  Trends Mol Med       Date:  2003-11       Impact factor: 11.951

10.  Crystallization and preliminary X-ray crystallographic analysis of human peptidylarginine deiminase V.

Authors:  Kyouhei Arita; Hiroshi Hashimoto; Toshiyuki Shimizu; Michiyuki Yamada; Mamoru Sato
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2003-11-27
View more
  6 in total

1.  Functional haplotypes of PADI4: relevance for rheumatoid arthritis specific synovial intracellular citrullinated proteins and anticitrullinated protein antibodies.

Authors:  T Cantaert; P Coucke; L De Rycke; E M Veys; F De Keyser; D Baeten
Journal:  Ann Rheum Dis       Date:  2005-03-10       Impact factor: 19.103

2.  Investigation of polymorphisms in the PADI4 gene in determining severity of inflammatory polyarthritis.

Authors:  A Barton; J Bowes; S Eyre; D Symmons; J Worthington; A Silman
Journal:  Ann Rheum Dis       Date:  2005-02-24       Impact factor: 19.103

3.  Are molecular haplotypes worth the time and expense? A cost-effective method for applying molecular haplotypes.

Authors:  Mark A Levenstien; Jürg Ott; Derek Gordon
Journal:  PLoS Genet       Date:  2006-06-28       Impact factor: 5.917

4.  PADI2 is significantly associated with rheumatoid arthritis.

Authors:  Xiaotian Chang; Yifang Xia; Jihong Pan; Qingsong Meng; Yan Zhao; Xinfeng Yan
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

5.  PADI4 haplotypes in association with RA Mexican patients, a new prospect for antigen modulation.

Authors:  Maria Guadalupe Zavala-Cerna; Norma Guadalupe Gonzalez-Montoya; Arnulfo Nava; Jorge I Gamez-Nava; Maria Cristina Moran-Moguel; Roberto Carlos Rosales-Gomez; Susan Andrea Gutierrez-Rubio; Jose Sanchez-Corona; Laura Gonzalez-Lopez; Ingrid Patricia Davalos-Rodriguez; Mario Salazar-Paramo
Journal:  Clin Dev Immunol       Date:  2013-12-22

6.  Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study.

Authors:  Berthold Hoppe; Thomas Häupl; Rudolf Gruber; Holger Kiesewetter; Gerd R Burmester; Abdulgabar Salama; Thomas Dörner
Journal:  Arthritis Res Ther       Date:  2006-01-16       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.